MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer.

Preclinical study results provide a comprehensive transcriptomic characterization of regenerative wound repair in the oral mucosa.

To better conduct the analysis of nucleoside analogues, hydrophilic interaction liquid chromatography–tandem mass ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

This article makes a valuable contribution to the field by uncovering a molecular mechanism for miRNA intracellular retention, mediated by the interaction of PCBP2, SYNCRIP, and specific miRNA motifs.

By tracking the movement of RNA molecules inside the nucleolus using advanced imaging and genomics techniques, the new method ...

Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

A strategy that analyzes the structural properties of RNA could help identify regions that are promising targets for antiviral drugs.

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...